Opus Genetics IRD Common Stock And Series A Preferred Stock Issued In Connection With Asset Acquisition
Common Stock And Series A Preferred Stock Issued In Connection With Asset Acquisition at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:CommonStockAndSeriesAPreferredStockIssuedInConnectionWithAssetAcquisition.
The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's common stock and series a preferred stock issued in connection with asset acquisition.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's common stock and series a preferred stock issued in connection with asset acquisition?
- Opus Genetics (IRD) reported common stock and series a preferred stock issued in connection with asset acquisition of $0 in Q4 2025.
- How has Opus Genetics's common stock and series a preferred stock issued in connection with asset acquisition changed year-over-year?
- Opus Genetics's common stock and series a preferred stock issued in connection with asset acquisition decreased by 100.0% year-over-year, from $6.45M to $0.
- What does common stock and series a preferred stock issued in connection with asset acquisition mean?
- Quantifies the non-cash value of equity instruments issued specifically to acquire assets or businesses. This metric is essential for understanding how the company utilizes its equity as a currency for inorganic growth without depleting cash reserves.